ClinicalTrials.Veeva

Menu

Pulmonary and Upper Limb Functions in Duchenne Muscular Dystrophy

H

Hacettepe University

Status

Completed

Conditions

Upper Limb Function
Respiratory Function Test
Duchenne Muscular Dystrophy

Treatments

Other: The Performance of Upper Limb Questionnaire (PUL)

Study type

Observational

Funder types

Other

Identifiers

NCT03552874
GO 16/773

Details and patient eligibility

About

Although it is known that the functions of pulmonary and upper limb is affected in late stage of Duchenne Muscular Dystrophy (DMD) negatively, the investigators do not have clear information about its early stage. The aim of this study was to investigate the differences in pulmonary and upper limb functions between children with DMD in early stage and healthy peers.

Enrollment

47 patients

Sex

Male

Ages

5 to 10 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

children with DMD was;

  • age between 5-10 years
  • being on treatment with corticosteroids for more than 6 months
  • being at Level I according to Brooke Upper and Lower Extremity Classification Systems

Healthy peers;

  • age between 5-10 years
  • not having any diagnosed disease

Exclusion criteria

• Children has undergo surgery and disease affect upper extremity or pulmonary function in last six months.

Trial design

47 participants in 2 patient groups

Patient Group
Description:
Children whose ages between 5-10 years with Duchenne Muscular Dystrophy.
Treatment:
Other: The Performance of Upper Limb Questionnaire (PUL)
Healthy Group
Description:
Healthy peers
Treatment:
Other: The Performance of Upper Limb Questionnaire (PUL)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems